Novavax to Participate in Upcoming September Conferences
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- S&P 500 and Nasdaq rise on cool inflation data, solid bank earnings
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- SK Hynix’s record plunge drags down global chip stocks
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- IBM misses Q2 targets as mainframe and software sales disappoint
- Goldman Sachs Upgrades NIO (NIO) to Buy
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- YPF Energía Eléctrica S.A. files for proposed NYSE IPO
Novavax (NVAX) Weakness Tied to Covid Vaccine Submission Delay
September 10, 2021 7:28 AM EDTNovavax (NASDAQ: NVAX) weakness Friday morning was tied to comments to investors that the submission of its Covid-19 shots to regulatory authorities would happen over the next few months. It had previously delayed plans to submit its application with UK regulators to the... More
